Categories: BrainNewsNutrition

Restart Life Introduces BrainBalls(TM) Product Line

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Vancouver, British Columbia–(Newsfile Corp. – June 5, 2025) – Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) (“Restart Life” or the “Company”) is pleased to announce the forthcoming launch of BrainBalls™, a functional wellness snack developed in collaboration with Brain Balls Inc. through a strategic joint venture established in December 2024.

BrainBalls™ represents the first consumer-facing product to emerge from this partnership and exemplifies Restart Life’s dedication to advancing wellness-oriented solutions for the modern consumer. Since forming the joint venture, Restart Life has taken the lead in reimagining the BrainBalls™ brand — overseeing every aspect of its transformation including product formulation, nutritional development, branding, and packaging design.

Crafted with clean-label, plant-based ingredients, BrainBalls™ is designed to support mental clarity, cognitive performance, sustained energy, and overall well-being. The initial product lineup will include three flavours: Chocolate, Vanilla, and Blueberry, with a focus on taste, functionality, and convenience. The snack will be available in both family size sachets and multi-pack travel options, tailored for busy, health-conscious individuals seeking functional foods that fit seamlessly into their daily routines.

BrainBalls™ Product Line

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8801/254507_7308c94434908872_001full.jpg

“BrainBalls™ is the result of many months of strategic collaboration and careful product development,” said Steve Loutskou, CEO of Restart Life Sciences. “It not only reflects our dedication to quality and innovation, but also demonstrates our commitment to delivering tangible wellness solutions that address the real needs of today’s consumers. We’re proud of the progress we’ve made and excited to introduce BrainBalls™ as the first of many products in our growing portfolio.”

In preparation for the launch, Restart Life Sciences is actively working with third-party manufacturers and logistics partners to ensure quality, scalability, and timely distribution. The Company plans to follow this debut with additional flavour varieties and product line extensions, as part of a broader strategy to expand its footprint in the functional food space.

The introduction of BrainBalls™ comes at a time of growing consumer demand for functional foods — particularly those that support cognitive health, energy, and mental performance. The global functional snack market is expected to continue its strong growth trajectory, driven by increased health awareness and demand for convenient nutrition. Restart Life aims to offer purpose-driven wellness products.

The Company intends to strategically time the launch of this product based on a range of internal and external variables, including the development pipeline of complementary brands within the Restart portfolio. This future launch underscores Restart Life’s mission to deliver accessible, high-quality solutions at the intersection of nutrition and performance. Leveraging its expertise, the Company is well-equipped to capitalize on emerging opportunities within this growing sector—supporting both long-term consumer demand and sustained shareholder value.

About Restart Life Sciences Corp.

Restart Life Science Corp. is a Canadian-based life sciences company listed on the CSE. For more information about Restart Life., please visit the Company’s website at www.restartlife.co.

Forward-Looking Statements

This news release contains statements that constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Restart Life Science’s actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or that events or conditions “will,” “would,” “may,” “could” or “should” occur.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

On behalf of the board of directors
Chief Executive Officer – Steve Loutskou
Tel: +1 (778) 819-0244
Email: hello@restartlife.co

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/254507

Staff

Recent Posts

CORRECTION FROM THE SOURCE: FloraWorks Highlights New Study Showing CBN Reverses Cognitive Decline in Aging Mice

Peer-reviewed research published in Redox Biology supports the therapeutic potential of Cannabinol (CBN) in brain…

3 hours ago

RXST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that the…

4 hours ago

Health-E Commerce® to Showcase flexible spending account (FSA) and health savings account (HSA) Engagement Tools at 38th Annual ECFC Symposium

FSA Store® and HSA Store® will demonstrate innovative e-commerce integrations, participant education resources, and compliance…

4 hours ago

Telemedicine Market to Reach USD 393.5 Billion by 2032, Driven by 15.1% CAGR | SkyQuest Technology Consulting

The telemedicine market is anticipated to increase due to the rising incidence of chronic diseases…

4 hours ago

Anywhere powered by Linus Health™ Expands Equitable Access to Early Detection of Cognitive Impairment

Fueled by successful community and clinical screenings, Linus Health brings its AI-powered remote cognitive assessment…

4 hours ago

Siemens Healthineers Receives Frost & Sullivan’s 2025 North America Company of the Year Award for Excellence in Advanced Visualization Applications

Recognized for delivering diagnostic innovation, workflow efficiency, and enterprise imaging leadership through advanced visualization solutions…

4 hours ago